Published in BMC Med Genomics on February 29, 2016
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54
Melanoma biology and new targeted therapy. Nature (2007) 10.71
MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med (2006) 4.60
Genomic Classification of Cutaneous Melanoma. Cell (2015) 3.91
A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One (2009) 3.83
In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res (2008) 3.66
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res (2006) 3.42
ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics (2010) 3.42
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics (2008) 3.11
Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet (2000) 2.63
Melanoma: from mutations to medicine. Genes Dev (2012) 2.59
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res (2012) 2.57
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol (2012) 2.41
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One (2008) 2.15
Main roads to melanoma. J Transl Med (2009) 1.67
Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol (2005) 1.66
Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J Biol Chem (2000) 1.45
"Transcription physiology" of pigment formation in melanocytes: central role of MITF. Exp Dermatol (2010) 1.45
Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci (2009) 1.38
Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res (2010) 1.38
The transcription factor Sox5 modulates Sox10 function during melanocyte development. Nucleic Acids Res (2008) 1.16
siPools: highly complex but accurately defined siRNA pools eliminate off-target effects. Nucleic Acids Res (2014) 1.01
Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology. Invest Ophthalmol Vis Sci (2009) 1.00
The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis. Nucleic Acids Res (2015) 0.99
Melanogenesis and melanoma. Pigment Cell Res (2003) 0.98
From melanocyte to metastatic malignant melanoma. Dermatol Res Pract (2010) 0.97
Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β. J Biol Chem (2012) 0.94
Regulation of gene expression in melanoma: new approaches for treatment. J Cell Biochem (2005) 0.92
The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun (2001) 0.91
Estimating the activity of transcription factors by the effect on their target genes. Bioinformatics (2014) 0.89
Evolution of promoter affinity for transcription factors in the human lineage. Mol Biol Evol (2011) 0.88
Clinical correlates of Breslow thickness of malignant melanoma. Br J Dermatol (2001) 0.86
Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma. Am J Clin Pathol (2001) 0.82
Hypoxia-independent drivers of melanoma angiogenesis. Front Oncol (2015) 0.82
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genet (2015) 0.81
Total Binding Affinity Profiles of Regulatory Regions Predict Transcription Factor Binding and Gene Expression in Human Cells. PLoS One (2015) 0.76